PMID- 10624951 OWN - NLM STAT- MEDLINE DCOM- 20000127 LR - 20190822 IS - 0896-6273 (Print) IS - 0896-6273 (Linking) VI - 24 IP - 4 DP - 1999 Dec TI - Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. PG - 879-92 AB - Mutant ataxin-1, the expanded polyglutamine protein causing spinocerebellar ataxia type 1 (SCA1), aggregates in ubiquitin-positive nuclear inclusions (NI) that alter proteasome distribution in affected SCA1 patient neurons. Here, we observed that ataxin-1 is degraded by the ubiquitin-proteasome pathway. While ataxin-1 [2Q] and mutant ataxin-1 [92Q] are polyubiquitinated equally well in vitro, the mutant form is three times more resistant to degradation. Inhibiting proteasomal degradation promotes ataxin-1 aggregation in transfected cells. And in mice, Purkinje cells that express mutant ataxin-1 but not a ubiquitin-protein ligase have significantly fewer NIs. Nonetheless, the Purkinje cell pathology is markedly worse than that of SCA1 mice. Taken together, NIs are not necessary to induce neurodegeneration, but impaired proteasomal degradation of mutant ataxin-1 may contribute to SCA1 pathogenesis. FAU - Cummings, C J AU - Cummings CJ AD - Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA. FAU - Reinstein, E AU - Reinstein E FAU - Sun, Y AU - Sun Y FAU - Antalffy, B AU - Antalffy B FAU - Jiang, Y AU - Jiang Y FAU - Ciechanover, A AU - Ciechanover A FAU - Orr, H T AU - Orr HT FAU - Beaudet, A L AU - Beaudet AL FAU - Zoghbi, H Y AU - Zoghbi HY LA - eng GR - HD37283/HD/NICHD NIH HHS/United States GR - NS22920/NS/NINDS NIH HHS/United States GR - NS27699/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Neuron JT - Neuron JID - 8809320 RN - 0 (ATXN1 protein, human) RN - 0 (Ataxin-1) RN - 0 (Ataxins) RN - 0 (Atxn1 protein, mouse) RN - 0 (Multienzyme Complexes) RN - 0 (Nerve Tissue Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Peptides) RN - 0 (Ubiquitins) RN - 26700-71-0 (polyglutamine) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 3.4.22.- (Cysteine Endopeptidases) RN - EC 3.4.25.1 (Proteasome Endopeptidase Complex) RN - EC 6.- (Ligases) SB - IM MH - Animals MH - Ataxin-1 MH - Ataxins MH - Cell Nucleus/*genetics/pathology MH - Cells, Cultured MH - Cysteine Endopeptidases/metabolism MH - Fluorescent Antibody Technique MH - HeLa Cells MH - Humans MH - Immunoblotting MH - Immunohistochemistry MH - Inclusion Bodies/*genetics/pathology MH - Ligases/deficiency/*genetics MH - Mice MH - Mice, Knockout MH - Microscopy, Confocal MH - Multienzyme Complexes/metabolism MH - Mutation/physiology MH - Nerve Tissue Proteins/biosynthesis/*genetics MH - Nuclear Proteins/biosynthesis/*genetics MH - Peptides/*toxicity MH - Phenotype MH - Plasmids/genetics MH - Proteasome Endopeptidase Complex MH - Purkinje Cells/metabolism/pathology/ultrastructure MH - Spinocerebellar Degenerations/*genetics/pathology MH - Ubiquitin-Protein Ligases MH - Ubiquitins/genetics/metabolism EDAT- 2000/01/07 00:00 MHDA- 2000/01/07 00:01 CRDT- 2000/01/07 00:00 PHST- 2000/01/07 00:00 [pubmed] PHST- 2000/01/07 00:01 [medline] PHST- 2000/01/07 00:00 [entrez] AID - S0896-6273(00)81035-1 [pii] AID - 10.1016/s0896-6273(00)81035-1 [doi] PST - ppublish SO - Neuron. 1999 Dec;24(4):879-92. doi: 10.1016/s0896-6273(00)81035-1.